R&D Views & Analysis | pharmaphorum

Views & Analysis

R&D

Can psychedelics provide breakthrough in mental health?

There is a growing pipeline of psychedelic therapies and an expanding body of science to suggest that they may be able to provide an alternative to existing mental health treatments.

Digital

AI tool helps detect leprosy using pictures

Ann Aerts, head of the Novartis Foundation, tells us about AI4Leprosy, a diagnostic assistant researchers developed that helps healthcare workers detect leprosy with over 90% accuracy using

R&D

Medical Informatics in Rare Disease – the bridge between two...

Rare diseases bring with them a multitude of challenges for those affected, their relatives and care providers.

R&D

Government pledges to work with industry to make UK a genomi...

With initiatives like The 100,000 Genome Project, the UK has led the world on genomic research.

Digital

Virtual and augmented reality: Bringing the future to pharma...

Virtual and augmented reality tools have reached a level of maturity to be utilised across various industries.

R&D

Using cross-functional teams to develop a product’s value st...

Tanya Brinsden, senior VP of operations at ICON Global Medical Communications and Pubs Hub, Jessica Cherian, VP of content and strategic services at ICON Market Access and Reimbursement, an